Extracorporeal Membrane Oxygenation for Treating Severe Cardiac and Respiratory Failure in Adults: Part 2—Technical Considerations

Horton, 1992, Pump-induced haemolysis: Is the constrained vortex pump better or worse than the roller pump?, Perfusion, 7, 103, 10.1177/026765919200700204

Bennett, 2004, Pump-induced haemolysis: A comparison of short-term ventricular assist devices, Perfusion, 19, 107, 10.1191/0267659104pf729oa

Thiara, 2007, Evaluation of oxygenators and centrifugal pumps for long-term pediatric extracorporeal membrane oxygenation, Perfusion, 22, 323, 10.1177/0267659107086270

Lawson, 2005, Hemolytic characteristics of three commercially available centrifugal blood pumps, Pediatr Crit Care Med, 6, 573, 10.1097/01.PCC.0000163282.63992.13

Peek, 2002, Early experience with a polymethyl pentene oxygenator for adult extracorporeal life support, ASAIO J, 48, 480, 10.1097/00002480-200209000-00007

Khoshbin, 2005, Poly-methyl pentene oxygenators have improved gas exchange capability and reduced transfusion requirements in adult extracorporeal membrane oxygenation, ASAIO J, 51, 281, 10.1097/01.MAT.0000159741.33681.F1

Plotz, 1993, Blood activation during neonatal extracorporeal life support, J Thorac Cardiovasc Surg, 105, 823, 10.1016/S0022-5223(19)34156-X

Moen, 1995, Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems, Ann Thorac Surg, 60, 1317, 10.1016/0003-4975(95)00777-I

Moen, 1997, Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass, Ann Thorac Surg, 63, 105, 10.1016/S0003-4975(96)00743-6

Fosse, 1994, Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass, Ann Thorac Surg, 58, 472, 10.1016/0003-4975(94)92231-4

Larm, 1983, A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue, Biomater Med Devices Artif Organs, 11, 161, 10.3109/10731198309118804

Pranikoff, 1999, Venovenous extracorporeal life support via percutaneous cannulation in 94 patients, Chest, 115, 818, 10.1378/chest.115.3.818

Smith, 2001, An extracorporeal membrane oxygenation-based approach to cardiogenic shock in an older population, Ann Thorac Surg, 71, 1421, 10.1016/S0003-4975(00)02504-2

Rich, 1998, A prospective comparison of atrio-femoral and femoro-atrial flow in adult venovenous extracorporeal life support, J Thorac Cardiovasc Surg, 116, 628, 10.1016/S0022-5223(98)70170-9

Ranasinghe, 2004, The use of transesophageal echocardiography to demonstrate obstruction of venous drainage cannula during ECMO, ASAIO J, 50, 619, 10.1097/01.MAT.0000142872.19219.C0

Kasirajan, 1999, Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation, Eur J Cardiothorac Surg, 15, 508, 10.1016/S1010-7940(99)00061-5

Hemmila, 2004, Extracorporeal life support for severe acute respiratory distress syndrome in adults, Ann Thorac Surg, 240, 595

Smedira, 2001, Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: Survival at five years, J Thorac Cardiovasc Surg, 122, 92, 10.1067/mtc.2001.114351

Mols, 2000, Extracorporeal membrane oxygenation: A ten-year experience, Am J Surg, 180, 144, 10.1016/S0002-9610(00)00432-3

Bartlett, 2000, Extracorporeal life support in the management of severe respiratory failure, Clin Chest Med, 21, 555, 10.1016/S0272-5231(05)70166-0

2008, Extracorporeal Life Support Registry Report (International Summary), 30

Burket, 1999, Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation, Clin Infect Dis, 28, 828, 10.1086/515200

O'Neill, 2001, Nosocomial infections during extracorporeal membrane oxygenation, Intensive Care Med, 27, 1247, 10.1007/s001340101029

Seib, 1999, Blade and balloon atrial septostomy for left heart decompression in patients with severe ventricular dysfunction on extracorporeal membrane oxygenation, Catheter Cardiovasc Interv, 46, 179, 10.1002/(SICI)1522-726X(199902)46:2<179::AID-CCD13>3.0.CO;2-W

Stroud, 2007, Successful use of extracorporeal membrane oxygenation in severe necrotizing pneumonia caused by Staphylococcus aureus, Pediatr Crit Care Med, 8, 282, 10.1097/01.PCC.0000262795.11598.56

Wittenstein, 2005, Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery, Pediatr Crit Care Med, 6, 473, 10.1097/01.PCC.0000162449.55887.B9

Bui, 2002, Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII, J Thorac Cardiovasc Surg, 124, 852, 10.1067/mtc.2002.126038

Chalwin, 2008, Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation, Eur J Cardiothorac Surg, 34, 685, 10.1016/j.ejcts.2008.05.022

Swaminathan, 2008, Fatal thrombosis after factor VII administration during extracorporeal membrane oxygenation, J Cardiothorac Vasc Anesth, 22, 259, 10.1053/j.jvca.2007.09.009

Bartlett, 2005, Management of ECLS in adult respiratory failure, 403

Fiser, 2001, When to discontinue extracorporeal membrane oxygenation for postcardiotomy support, Ann Thorac Surg, 71, 210, 10.1016/S0003-4975(00)02340-7

Doll, 2004, Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock, Ann Thorac Surg, 77, 151, 10.1016/S0003-4975(03)01329-8

Massetti, 2005, Back from irreversibility: Extracorporeal life support for prolonged cardiac arrest, Ann Thorac Surg, 79, 178, 10.1016/j.athoracsur.2004.06.095